Lysosomal storage diseases in the era of COVID-19: a report of an Egyptian case of alpha-fucosidosis and a summary of the lysosomal storage diseases-COVID-19 relationship.

Published in: The Egyptian journal of medical human genetics (2022)

Patients with lysosomal storage diseases with local or systemic immune suppression may be predisposed to respiratory complications of COVID-19. Intense care with protective guidelines should be applied to those patients.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
newly diagnosed
healthcare
chronic kidney disease
respiratory syndrome coronavirus
prognostic factors
risk factors
quality improvement
clinical practice
chronic pain
patient reported